Semaglutide has long been shown to cause medullary thyroid mobile carcinoma in rodents. Though its scientific relevance to humans is mysterious, the FDA advises not to administer this drug in Those people with a personal or relatives heritage of medullary thyroid carcinoma. Semaglutide also poses a risk of pancreatitis and dehydration.Older individ